Medicines Company (MDCO-OLD)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity Share change % change to portfolio
Q1  2020
Lee Ainslie - Maverick Capital Sell 100.00% 2,176,487 2.69
David Einhorn - Greenlight Capital Sell 100.00% 229,900 1.45
First Eagle Investment Management Sell 100.00% 409,112 0.10
Q4  2019
David Einhorn - Greenlight Capital Reduce 68.58% 501,700 3.16
Lee Ainslie - Maverick Capital Reduce 43.96% 1,707,552 2.11
First Eagle Investment Management Reduce 46.45% 354,900 0.09
Q3  2019
Lee Ainslie - Maverick Capital Add 0.44% 16,956 0.01
Q2  2019
David Einhorn - Greenlight Capital Reduce 22.89% 217,200 0.58
Lee Ainslie - Maverick Capital Add 1.38% 52,731 0.03
Q1  2019
Lee Ainslie - Maverick Capital Add 8.52% 299,375 0.11
Q4  2018
Lee Ainslie - Maverick Capital Add 157.54% 2,150,140 0.61
Q3  2018
Lee Ainslie - Maverick Capital Add 13.24% 159,556 0.06
David Einhorn - Greenlight Capital Reduce 5.12% 51,200 0.06
Q2  2018
Lee Ainslie - Maverick Capital Add 33.00% 299,030 0.13
Q1  2018
Lee Ainslie - Maverick Capital Buy 906,251 0.39
Q4  2017
David Einhorn - Greenlight Capital Buy 1,000,000 0.50

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.